Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Rank in Stocks #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Share Price
$8.92
Last synced: 2024-10-18
Market Cap
$674.03M
Change (1 day)
-5.14%
Change (1 year)
0.00%
Country
KR
Trade Jeisys Medical Inc. (287410)

Category

Number of shares outstanding for Jeisys Medical Inc. (287410)
Number of shares outstanding as of June 2024: 77.36M
According to Jeisys Medical Inc. latest financial reports and stock price the company's current number of shares outstanding is 77.36M. At the end of December 2022 the company had 71.21M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Jeisys Medical Inc. (287410) from 2020 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 77.36M 2.31%
2023 75.61M 6.19%
2022 71.21M 2.16%
2021 69.70M 0.00%
2020 69.70M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
1.74B 2,153.25%
US
383.50M 395.75%
US
1.28B 1,557.37%
IE
1.48B 1,810.10%
US
- -
DE